Skip to main content

Sara Escalera Anzola

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Sara Escalera Anzola

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Jordi Riera del Brío

Jordi Riera del Brío

Shock, Organ Dysfunction and Resuscitation
Read more
Laura Alonso Garcia

Laura Alonso Garcia

Senior researcher
Childhood Cancer and Blood Disorders
Read more
Maider Arando Lasagabaster

Maider Arando Lasagabaster

Infectious Diseases
Read more
Imanol Setien Ramos

Imanol Setien Ramos

Research assistant
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.